Leah Jones Sells 7,000 Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Stock

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRXGet Rating) CFO Leah Jones sold 7,000 shares of the business’s stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $16.62, for a total value of $116,340.00. Following the completion of the sale, the chief financial officer now directly owns 98,362 shares of the company’s stock, valued at $1,634,776.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Leah Jones also recently made the following trade(s):

  • On Wednesday, August 17th, Leah Jones sold 3,921 shares of Allscripts Healthcare Solutions stock. The shares were sold at an average price of $17.65, for a total value of $69,205.65.
  • On Monday, August 15th, Leah Jones sold 24 shares of Allscripts Healthcare Solutions stock. The shares were sold at an average price of $17.65, for a total value of $423.60.

Allscripts Healthcare Solutions Stock Performance

NASDAQ MDRX opened at $16.67 on Friday. The company has a current ratio of 3.23, a quick ratio of 3.23 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average is $16.27 and its two-hundred day moving average is $18.20. Allscripts Healthcare Solutions, Inc. has a 12-month low of $13.05 and a 12-month high of $23.25. The stock has a market capitalization of $1.85 billion, a price-to-earnings ratio of 38.77, a PEG ratio of 1.44 and a beta of 0.98.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last released its quarterly earnings results on Thursday, August 4th. The software maker reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. The business had revenue of $150.90 million for the quarter, compared to analysts’ expectations of $148.58 million. Allscripts Healthcare Solutions had a return on equity of 10.62% and a net margin of 5.90%. The company’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.17 EPS. Research analysts expect that Allscripts Healthcare Solutions, Inc. will post 0.71 EPS for the current year.

Institutional Investors Weigh In On Allscripts Healthcare Solutions

A number of institutional investors and hedge funds have recently modified their holdings of the company. Mutual of America Capital Management LLC grew its holdings in shares of Allscripts Healthcare Solutions by 5.5% in the 1st quarter. Mutual of America Capital Management LLC now owns 17,662 shares of the software maker’s stock worth $398,000 after acquiring an additional 916 shares during the period. Comerica Bank grew its holdings in shares of Allscripts Healthcare Solutions by 0.7% in the 1st quarter. Comerica Bank now owns 132,129 shares of the software maker’s stock worth $3,013,000 after acquiring an additional 940 shares during the period. Raymond James & Associates grew its holdings in shares of Allscripts Healthcare Solutions by 3.9% in the 4th quarter. Raymond James & Associates now owns 25,284 shares of the software maker’s stock worth $466,000 after acquiring an additional 950 shares during the period. Teacher Retirement System of Texas grew its holdings in shares of Allscripts Healthcare Solutions by 4.0% in the 1st quarter. Teacher Retirement System of Texas now owns 25,158 shares of the software maker’s stock worth $567,000 after acquiring an additional 977 shares during the period. Finally, Bank of Montreal Can lifted its stake in Allscripts Healthcare Solutions by 3.6% in the 1st quarter. Bank of Montreal Can now owns 34,210 shares of the software maker’s stock valued at $768,000 after buying an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 99.76% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on MDRX. Piper Sandler dropped their price target on Allscripts Healthcare Solutions from $19.00 to $17.00 in a research report on Thursday, June 9th. KeyCorp began coverage on Allscripts Healthcare Solutions in a research report on Thursday. They issued a “sector weight” rating on the stock. Finally, The Goldman Sachs Group began coverage on Allscripts Healthcare Solutions in a research report on Tuesday, July 12th. They issued a “neutral” rating and a $21.00 price target on the stock. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.80.

Allscripts Healthcare Solutions Company Profile

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.